Celularity Inc.
CELU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $54,540 | $47,080 | $40,708 | $46,492 |
| - Cash | $120 | $863 | $293 | $738 |
| + Debt | $65,324 | $70,154 | $69,776 | $68,836 |
| Enterprise Value | $119,744 | $116,371 | $110,191 | $114,590 |
| Revenue | $5,284 | $5,736 | $11,426 | $18,132 |
| % Growth | -7.9% | -49.8% | -37% | – |
| Gross Profit | $3,266 | $494 | $7,872 | $10,789 |
| % Margin | 61.8% | 8.6% | 68.9% | 59.5% |
| EBITDA | -$19,733 | -$20,747 | -$15,483 | -$7,597 |
| % Margin | -373.4% | -361.7% | -135.5% | -41.9% |
| Net Income | -$23,073 | -$24,524 | -$19,754 | -$13,293 |
| % Margin | -436.7% | -427.5% | -172.9% | -73.3% |
| EPS Diluted | -0.876 | -1.021 | -0.84 | -0.595 |
| % Growth | 14.2% | -21.6% | -41.2% | – |
| Operating Cash Flow | -$4,159 | -$999 | -$2,993 | $1,594 |
| Capital Expenditures | $0 | $0 | $0 | -$56 |
| Free Cash Flow | -$4,159 | -$999 | -$2,993 | $1,538 |